Elsevier Appoints Martin O’Malley as Managing Director of New Global Sales Group in Science & Technology Division
Amsterdam, 1 July, 2010 – Elsevier, the leading publisher of scientific, technical and medical information, has appointed Martin O’Malley as Managing Director of the newly formed Global Sales & Customer Marketing group in the Science & Technology (S&T) division, which includes the sales teams for Academic & Government, Books and Corporate Markets, effective 1 July.
O’Malley’s appointment follows the announced departure of Roy Jakobs, Managing Director for Academic & Government Sales and Customer Marketing. Jakobs will be leaving Elsevier this summer to take a senior position in the lighting division of Philips.
“Martin O’Malley is a leader who brings great knowledge of Elsevier’s customers to his new position,“ said Youngsuk Chi, Vice Chairman and CEO S&T. “In Martin, we have a leader who has on-the-ground experience in the Americas, Europe and the Asia Pacific region, as well as experience with a wide range of customers and partners across academic and government research, education, and corporate research and development,” he added.
“I am very excited about this new role and our continued strong focus on the needs of customers in the academic, government, corporate, and professional communities,” said Martin O’Malley. “At the same time, by bringing together the wider Elsevier sales and marketing effort, we expect to further improve our ability to address shared needs across different customer groups,” he continued.
O’Malley’s position as Managing Director of Corporate Markets will be taken over by Alexander van Boetzelaer, who will spearhead the continuing effort to develop Elsevier’s corporate business.About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).Media Contact
Tel: +31 20 485 27 36